Acadia Healthcare

ACHC · NYSE · Healthcare · United States

Financials at a glance

Source: SEC XBRL

Annual

FY2023FY2024FY2025$2.9B$2.9B$3.2B$3.2B$3.3B$3.3B-33.3% margin-33.3% marginRevenueNet margin

Quarterly · last 8

Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26$796.0M$796.0M$815.6M$815.6M$770.5M$770.5M$869.2M$869.2M$851.6M$851.6M$828.8M$828.8M0.5% margin0.5% marginRevenueNet margin

Revenue (FY2025)

$3.3B

Net margin

-33.3%

ROE

-56.6%

Revenue CAGR (2y)

+6.4%

EPS (FY2025)

-12.16

Net profit (FY2025)

$-1.1B

Ask MarketChacha about ACHC

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Why it moved

  • Aug 25, 2026

    ACHC rose with broader market/sector sentiment; no specific company catalyst or filing was reported for August 25, following mid-August discussion of its raised 2026 EBITDA guidance.

    · confidence: low
  • Aug 4, 2026

    No clear company-specific catalyst today; ACHC rose with broader market/sector sentiment following recent BlackRock stake increase and post-earnings stabilization after July 31 guidance update.

    source 1source 2· confidence: low
  • Jul 29, 2026

    Acadia Healthcare shares plunged after its Q2 2026 earnings release showed a sharp y/y drop in net income, Adjusted EBITDA, and Adjusted EPS (driven by higher PLGL costs and lower supplemental payment benefits), plus full-year 2026 revenue guidance that missed consensus expectations despite an adjusted EPS beat and in-line revenue.

    source 1source 2· confidence: high
  • Jul 27, 2026

    Acadia Healthcare shares fell as a court denied the company's motion to dismiss a securities class action lawsuit, allowing claims over alleged patient admission, detention, and billing practices to proceed.

    source 1· confidence: medium

Daily moves with the verified reason behind them. Education only — not investment advice.

Financials

Yearly

PeriodRevenueNet profitEPSNet marginROE
FY2025$3.3B$-1.1B-12.16-33.3%-56.6%
FY2024$3.2B$255.6M2.788.1%8.3%
FY2023$2.9B$-21.7M-0.24-0.7%-0.8%

Quarterly

PeriodRevenueNet profitEPSNet margin
2026Q1$828.8M$4.1M0.050.5%
2025Q4$-1.2B
2025Q3$851.6M$36.2M0.404.3%
2025Q2$869.2M$30.1M0.333.5%
2025Q1$770.5M$8.4M0.091.1%
2024Q4$32.6M
2024Q3$815.6M$68.1M0.748.4%
2024Q2$796.0M$78.5M0.859.9%
2024Q1$768.1M$76.4M0.839.9%
2023Q4$57.7M
2023Q3$750.3M$-217.7M-2.39-29.0%
2023Q2$731.3M$72.3M0.799.9%
2023Q1$704.3M$66.0M0.729.4%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.